Vanguard Group’s Lexaria Bioscience LEXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Buy |
133,554
+5,683
| +4% | +$4.94K | ﹤0.01% | 4138 |
|
|
2025
Q1 | $219K | Buy |
127,871
+438
| +0.3% | +$749 | ﹤0.01% | 4056 |
|
|
2024
Q4 | $268K | Buy |
127,433
+18,411
| +17% | +$38.7K | ﹤0.01% | 4058 |
|
|
2024
Q3 | $333K | Buy |
109,022
+15,436
| +16% | +$47.1K | ﹤0.01% | 4057 |
|
|
2024
Q2 | $260K | Buy |
93,586
+8,430
| +10% | +$23.4K | ﹤0.01% | 4130 |
|
|
2024
Q1 | $309K | Buy |
85,156
+38,915
| +84% | +$141K | ﹤0.01% | 4109 |
|
|
2023
Q4 | $57.8K | Buy |
46,241
+12,912
| +39% | +$16.1K | ﹤0.01% | 4357 |
|
|
2023
Q3 | $33.3K | Hold |
33,329
| – | – | ﹤0.01% | 4454 |
|
|
2023
Q2 | $24.3K | Hold |
33,329
| – | – | ﹤0.01% | 4510 |
|
|
2023
Q1 | $90.7K | Hold |
33,329
| – | – | ﹤0.01% | 4417 |
|
|
2022
Q4 | $82K | Buy |
33,329
+165
| +0.5% | +$406 | ﹤0.01% | 4410 |
|
|
2022
Q3 | $81K | Sell |
33,164
-958
| -3% | -$2.34K | ﹤0.01% | 4509 |
|
|
2022
Q2 | $102K | Hold |
34,122
| – | – | ﹤0.01% | 4548 |
|
|
2022
Q1 | $112K | Hold |
34,122
| – | – | ﹤0.01% | 4588 |
|
|
2021
Q4 | $138K | Buy |
34,122
+3,288
| +11% | +$13.3K | ﹤0.01% | 4591 |
|
|
2021
Q3 | $193K | Buy |
30,834
+4,858
| +19% | +$30.4K | ﹤0.01% | 4488 |
|
|
2021
Q2 | $182K | Buy |
+25,976
| New | +$182K | ﹤0.01% | 4376 |
|